Debbi, K.; Grellier, N.; Loganadane, G.; Boukhobza, C.; Mahé, M.; Cherif, M.A.; Rida, H.; Gligorov, J.; Belkacemi, Y.
Interaction between Radiation Therapy and Targeted Therapies in HER2-Positive Breast Cancer: Literature Review, Levels of Evidence for Safety and Recommendations for Optimal Treatment Sequence. Cancers 2023, 15, 2278.
https://doi.org/10.3390/cancers15082278
AMA Style
Debbi K, Grellier N, Loganadane G, Boukhobza C, Mahé M, Cherif MA, Rida H, Gligorov J, Belkacemi Y.
Interaction between Radiation Therapy and Targeted Therapies in HER2-Positive Breast Cancer: Literature Review, Levels of Evidence for Safety and Recommendations for Optimal Treatment Sequence. Cancers. 2023; 15(8):2278.
https://doi.org/10.3390/cancers15082278
Chicago/Turabian Style
Debbi, Kamel, Noémie Grellier, Gokoulakrichenane Loganadane, Chahrazed Boukhobza, Mathilde Mahé, Mohamed Aziz Cherif, Hanan Rida, Joseph Gligorov, and Yazid Belkacemi.
2023. "Interaction between Radiation Therapy and Targeted Therapies in HER2-Positive Breast Cancer: Literature Review, Levels of Evidence for Safety and Recommendations for Optimal Treatment Sequence" Cancers 15, no. 8: 2278.
https://doi.org/10.3390/cancers15082278
APA Style
Debbi, K., Grellier, N., Loganadane, G., Boukhobza, C., Mahé, M., Cherif, M. A., Rida, H., Gligorov, J., & Belkacemi, Y.
(2023). Interaction between Radiation Therapy and Targeted Therapies in HER2-Positive Breast Cancer: Literature Review, Levels of Evidence for Safety and Recommendations for Optimal Treatment Sequence. Cancers, 15(8), 2278.
https://doi.org/10.3390/cancers15082278
